Early onset, anatomic site, and lack of relation to UV damage in BRAF-mutated CM reflect the distinct pathogenic pathways of melanocyte malignization, which are different from those of wild-type melanoma [18] and can also define the roots of the found predictive significance of the associated nevus on the probability of harboring BRAF mutations in CM. This evidence concerns the gene BRAF and melanoma.